Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
Abstract Atrial fibrillation (AF) and heart failure (HF) contribute to about 45% of all cardiovascular disease (CVD) deaths in the USA and around the globe. Due to the complex nature, progression, inherent genetic makeup, and heterogeneity of CVDs, personalized treatments are believed...
| 主要な著者: | , , , , , , |
|---|---|
| その他の著者: | |
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
BioMed Central
2023
|
| オンライン･アクセス: | https://hdl.handle.net/1721.1/150862 |